RFK Jr.’s plan for pharma ads would run straight into the First Amendment
Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...
ClearBridge Large Cap Growth ESG Strategy Q4 2024 Commentary
The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.
Eli Lilly's SWOT analysis: stock soars on GLP-1 success, faces competition challenges
Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...
Eli Lilly Stock's Correction Brings Opportunity
Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.
Is Eli Lilly and Company (LLY) the Best Stock to Buy in 2025 for Beginners?
We recently published a list of the 12 Best Stocks to Buy in 2025 for Beginners. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best ...
Could Cutting DEI In Medicine Cost Lives? The High-Stakes Impact Of Trump’s Executive Order
The Food & Drug Administration (FDA), has quietly taken down their guidance detailing diversity action plans for clinical ...
Geneos Wealth Management Inc. Reduces Stock Position in 3M (NYSE:MMM)
Geneos Wealth Management Inc. lessened its holdings in shares of 3M (NYSE:MMM – Free Report) by 2.8% during the fourth ...
MarketWatch20h
S&P 500 Index
Paccar Inc. $110.83 3.58 3.34% ...